Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Abraxane for Refractory Bladder Cancer
NCT00583349Phase 2Completed
- Sponsor
- Columbia University
- Start
- Dec 2008
- Primary completion
- Mar 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in bladder cancer, sponsored by Columbia University. Started Dec 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00583349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583349.